Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-12 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −17,724 $90.56 $1.6M 0
2026-11-11 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −3,044 $90.03 $274K 0
2026-11-10 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −2,561 $90.14 $231K 0
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −300 $85.16 $26K 100,413
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −700 $86.70 $61K 99,713
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −1,736 $88.84 $154K 97,977
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −37,517 $90.12 $3.4M 60,460
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −58,396 $90.90 $5.3M 2,064
2026-11-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −2,064 $91.59 $189K 0
2026-09-17 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −7,928 $100.43 $796K 12,072
2026-09-17 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −6,771 $101.37 $686K 5,301
2026-09-17 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −3,501 $102.39 $358K 1,800
2026-09-17 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −1,100 $103.20 $114K 700
2026-09-17 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −700 $104.39 $73K 0
2026-09-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −2,600 $105.19 $273K 24,524
2026-09-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −7,215 $106.25 $767K 17,309
2026-09-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −13,309 $106.74 $1.4M 4,000
2026-08-19 Read Simon Director Sale 10b5-1 −2,778 $117.55 $327K 0
2026-08-10 McGeorge Anne Director Sale 10b5-1 −1,450 $107.58 $156K 6,300
2026-08-10 McGeorge Anne Director Sale 10b5-1 −2,800 $108.38 $303K 3,500

Page 1 of 6 · 119 trades